Chengbo Han

Peking University

SCHOLARLY PAPERS

1

DOWNLOADS

20

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Intracranial Efficacy of Crizotinib and Superior Post-Progression Outcomes with Next-Generation ROS1 Inhibitors in Advanced ROS1-Rearranged NSCLC: A Chinese Multi-Center Real-World Study

Number of pages: 30 Posted: 07 May 2025
Capital Medical University - Beijing Chest Hospital, Fujian Medical University - Fujian Cancer Hospital, Capital Medical University - Beijing Chest Hospital, Sichuan University - Department of Respiratory & Critical Care Medicine, Capital Medical University - Beijing Chest Hospital, Fudan University, Zhejiang University, Zhejiang University - Key Laboratory of Respiratory Disease of Zhejiang Province, Xiamen University, Nanjing Medical University, Government of the People's Republic of China - Department of Respiratory Medicine, Tianjin Medical University, University of Electronic Science and Technology of China (UESTC), Huazhong University of Science and Technology - Department of Oncology, Nanjing Medical University - Jiangsu Cancer Hospital, Peking University, Peking University, Tianjin Medical University - Tianjin Cancer Institute and Xi'an Jiaotong University (XJTU)
Downloads 20 (1,162,516)

Abstract:

Loading...

Non-small cell lung cancer, Crizotinib, ROS1, CNS efficacy, Subsequent treatments